Insider Selling: Addus HomeCare Co. (NASDAQ:ADUS) EVP Sells 2,250 Shares of Stock

Addus HomeCare Co. (NASDAQ:ADUS) EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the sale, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Addus HomeCare Trading Up 1.9 %

ADUS traded up $2.23 on Tuesday, hitting $122.96. 89,441 shares of the stock traded hands, compared to its average volume of 130,493. The business has a fifty day moving average price of $126.01 and a two-hundred day moving average price of $124.24. The firm has a market capitalization of $2.23 billion, a PE ratio of 27.62, a P/E/G ratio of 2.11 and a beta of 1.02. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. Addus HomeCare’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.03 earnings per share. On average, equities research analysts forecast that Addus HomeCare Co. will post 4.59 EPS for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Institutional investors and hedge funds have recently bought and sold shares of the business. SG Americas Securities LLC bought a new position in shares of Addus HomeCare during the 2nd quarter worth about $842,000. Diversified Trust Co raised its position in Addus HomeCare by 9.4% in the second quarter. Diversified Trust Co now owns 2,673 shares of the company’s stock worth $310,000 after purchasing an additional 230 shares in the last quarter. Ellsworth Advisors LLC bought a new position in Addus HomeCare during the second quarter worth about $598,000. Blue Trust Inc. acquired a new stake in Addus HomeCare during the second quarter valued at approximately $310,000. Finally, Summit Global Investments grew its stake in shares of Addus HomeCare by 7.9% in the 2nd quarter. Summit Global Investments now owns 10,752 shares of the company’s stock valued at $1,248,000 after purchasing an additional 790 shares during the period. Institutional investors own 95.35% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on ADUS shares. Stephens lifted their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Royal Bank of Canada restated an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a report on Thursday, November 14th. Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a research report on Monday, September 23rd. KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. Finally, Macquarie reaffirmed an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.